Skip to main content

Table 1 Baseline characteristics stratified by the first endpoint (adverse outcome)

From: Association of the Tyrosine/Nitrotyrosine pathway with death or ICU admission within 30 days for patients with community acquired pneumonia

Factor

Level

Total

Non-adverse outcome at 30d

Adverse outcome at 30d

p-value

N

 

278

249 (89.6%)

29 (10.4%)

 

Demographics

 Age in years median (IQR)

71.5 (57, 82)

71 (57, 82)

76 (67, 83)

0.078

 Gender, n (%)

Male

165 (59.4%)

147 (59.0%)

18 (62.1%)

0.75

Female

113 (40.6%)

102 (41.0%)

11 (37.9%)

 

 BMI, median (IQR)

24.8 (22.0, 27.7)

24.6 (21.8, 27.5)

26.6 (24.4, 29.5)

0.053

Comorbidities

 Coronary Heart Disease, n (%)

52 (18.7%)

44 (17.7%)

8 (27.6%)

0.2

 Congestive Heart Failure, n (%)

35 (12.6%)

31 (12.4%)

4 (13.8%)

0.84

 Chronic Kidney Disease, n (%)

67 (24.1%)

51 (20.5%)

16 (55.2%)

< 0.001

 Diabetes mellitus, n (%)

41 (14.7%)

36 (14.5%)

5 (17.2%)

0.69

 Tumor, n (%)

33 (11.9%)

27 (10.8%)

6 (20.7%)

0.12

 COPD, n (%)

73 (26.3%)

61 (24.5%)

12 (41.4%)

0.051

Vital signs

 Pulse rate, bpm, median (IQR)

94 (82, 107)

94 (82.5, 106)

97 (75, 114)

0.75

 Temperature, °C, median (IQR)

38 (37.2, 38.9)

38 (37.2, 39)

37.4 (36.7, 38.4)

0.014

 Systolic BP, mmHg, median (IQR)

130 (118, 146)

131 (120, 147)

124 (102, 139)

0.044

Clinical scores

 PSI-Score

1, 2

73 (26.3%)

70 (28.1%)

3 (10.3%)

< 0.001

3

56 (20.1%)

55 (22.1%)

1 (3.4%)

 

4, 5

149 (53.6%)

124 (49.8%)

25 (86.2%)

 

 CURB-65-Score

0, 1

125 (45.0%)

120 (48.2%)

5 (17.2%)

< 0.001

2, 3

139 (50.0%)

123 (49.4%)

16 (55.2%)

 

4, 5

14 (5.0%)

6 (2.4%)

8 (27.6%)

 

Markers of oxidative stress and inflammation

 Tyrosine, median (IQR)

 

81.7 (63.2, 118.0)

81.6 (61.8, 117.0)

84.0 (66.4, 122.0)

0.33

 Tyr-NO2, median (IQR)

 

1.5 (0.8, 11.7)

1.5 (0.9, 12.3)

1.4 (0.5, 4.0)

0.29

 Ratio Tyr-NO2/Tyrosine, median (IQR)

2.0 (1.0, 7.6)

2.1 (1.0, 8.3)

1.9 (0.9, 3.5)

0.19

 CRP, median (IQR)

 

136 (63, 252)

132 (61, 246)

176 (106, 336)

0.032

 PCT, median (IQR)

 

0.45 (0.16, 3.20)

0.40 (0.15, 2.96)

0.64 (0.21, 6.30)

0.13

  1. Bolded p-values are statistically significant at p < 0.05. BMI, Body Mass Index; COPD, chronic obstructive pulmonary disease; bpm, beats per minute; BP, blood pressure; PSI Pneumonia Severity Index; CURB-65, score of confusion, urea, respiratory rate, blood pressure, age; CRP, initial C-reactive Protein level; PCT, initial Procalcitonin level; WBC, initial leukocyte count